Specifications include, but are not limited to: The Ohio Opioid Abuse Prevention and Treatment Initiative (“Program”) is to accelerate the development and commercialization of promising new products (or adaptations or modifications) in categories of medical devices, diagnostics, pharmaceuticals, and health technology to meaningfully address one or more issues associated with the drug crisis driven by use, misuse, abuse and addictive potential of opioids. Specifically, projects must contribute to near term tangible solutions associated with addiction prevention, treatment and overdose intervention. Technology and products that enable safe and effective treatment of acute and chronic pain without the use of opioids are encouraged. Projects advancing technologies that have already achieved technical proof of concept and for which there is evidence of interest by a potential end-user are the focus of the Program. Proposals to support products that are already in the market are eligible where the objective of the project is to adapt or modify those products to enable reduction of abuse, addictive potential and morbidity and mortality associated with opioid use. This includes technologies that address overdose prevention, treatment and recovery. Basic research projects are not eligible for funding